Clinical Trial Update: Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion [NA]

View source ↗

Summary

This completed clinical trial evaluated factors that predict visual improvement in patients with retinal vein occlusion undergoing intravitreal ranibizumab ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: St. Marianna University School of Medicine | Conditions: Researcher-Subject Relations | NA | Status: COMPLETED